Literature DB >> 9112985

Beta-ig. Molecular cloning and in situ hybridization in corneal tissues.

I M Rawe1, Q Zhan, R Burrows, K Bennett, C Cintron.   

Abstract

PURPOSE: To identify a protein that copurifies with type VI collagen from rabbit cornea and to determine its cell source in rabbit corneal tissues by in situ hybridization.
METHODS: Type VI collagen was extracted from cornea with urea and purified by ammonium sulfate precipitation and gel chromatography. The purity of the collagen was assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). On reduction with mercaptoethanol or dithiothreitol, the alpha chains of type VI collagen ran into the gel. In addition to the type VI collagen polypeptides, an extra 68-kDa protein band appeared, suggesting that this protein is present as a large molecular weight component before reduction. Amino acid sequencing indicated that protein was related to beta ig-h3 from humans. Western blot analysis was used to determine immunologic similarity to this human protein. A rabbit stromal cell cDNA library was screened with human beta ig-h3 cDNA probe. Positive clones were sequenced and analyzed for sequence homology. Oligonucleotide probes prepared from rabbit cDNA sequences were used for Northern blot analysis and in situ hybridization of corneal tissues.
RESULTS: Electroblotting of the SDS-PAGE and amino acid sequence analysis of the first 10 N-terminal amino acids of the 68-kDa band gave 100% homology with a known protein produced by human adenocarcinoma cells, beta ig-h3. This 68-kDa protein was identical immunologically to beta ig-h3 by Western blot analysis. Sequence analysis of a rabbit cDNA clone contained the whole coding region and had high identity with both human beta ig-h3 and mouse beta ig-m3. The deduced amino acid sequence had 92% identity with these species. An oligonucleotide probe from the rabbit cDNA sequence detected a single band of mRNA from cultures of stromal cells consistent in size with human beta ig-h3 mRNA. The authors refer to the rabbit form of beta ig-h3 as beta ig because the protein was obtained from normal rabbit cornea and the mRNA comes from primary cultures of rabbit stromal cells and not from a cloned cell line. In situ hybridization of rabbit corneal tissue indicated that the beta ig mRNA is located primarily in the epithelium of normal adult cornea, in fetal stromal cells, and both endothelium- and stroma-derived cells in healing corneal wounds. Normal adult endothelium and stroma did not show beta ig mRNA label.
CONCLUSIONS: The highly conserved amino acid sequence homology between the human, mouse, and rabbit proteins and the temporal expression of beta ig message during corneal healing and development suggest this protein plays an important role in the morphogenesis of corneal tissues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9112985

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  21 in total

1.  Unique TGFBI protein in lattice corneal dystrophy.

Authors:  Yu-Ping Han; Austin J Sim; Smita C Vora; Andrew J W Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-28       Impact factor: 4.799

2.  Keratoepithelin in secondary corneal amyloidosis.

Authors:  D Suesskind; C Auw-Haedrich; D F Schorderet; F L Munier; K U Loeffler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-06       Impact factor: 3.117

3.  Human phenotypically distinct TGFBI corneal dystrophies are linked to the stability of the fourth FAS1 domain of TGFBIp.

Authors:  Kasper Runager; Rajiv V Basaiawmoit; Taru Deva; Maria Andreasen; Zuzana Valnickova; Charlotte S Sørensen; Henrik Karring; Ida B Thøgersen; Gunna Christiansen; Jarl Underhaug; Torsten Kristensen; Niels Chr Nielsen; Gordon K Klintworth; Daniel E Otzen; Jan J Enghild
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

4.  Proteomic profiling of TGFBI-null mouse corneas reveals only minor changes in matrix composition supportive of TGFBI knockdown as therapy against TGFBI-linked corneal dystrophies.

Authors:  Ebbe Toftgaard Poulsen; Kasper Runager; Nadia Sukusu Nielsen; Marie V Lukassen; Karen Thomsen; Paige Snider; Olga Simmons; Henrik Vorum; Simon J Conway; Jan J Enghild
Journal:  FEBS J       Date:  2017-11-23       Impact factor: 5.542

5.  Suppression of keratoepithelin and myocilin by small interfering RNA (an American Ophthalmological Society thesis).

Authors:  Andrew J W Huang
Journal:  Trans Am Ophthalmol Soc       Date:  2007

6.  Early Events in the Amyloid Formation of the A546T Mutant of Transforming Growth Factor β-Induced Protein in Corneal Dystrophies Compared to the Nonfibrillating R555W and R555Q Mutants.

Authors:  Heidi Koldsø; Ole Juul Andersen; Camilla Lund Nikolajsen; Carsten Scavenius; Charlotte S Sørensen; Jarl Underhaug; Kasper Runager; Niels Chr Nielsen; Jan J Enghild; Birgit Schiøtt
Journal:  Biochemistry       Date:  2015-09-02       Impact factor: 3.162

7.  Corneal dystrophy-associated R124H mutation disrupts TGFBI interaction with Periostin and causes mislocalization to the lysosome.

Authors:  Bong-Yoon Kim; James A Olzmann; Seung-Il Choi; So Yeon Ahn; Tae-Im Kim; Hyun-Soo Cho; Hwal Suh; Eung Kweon Kim
Journal:  J Biol Chem       Date:  2009-05-28       Impact factor: 5.157

8.  Colocalization of increased transforming growth factor-beta-induced protein (TGFBIp) and Clusterin in Fuchs endothelial corneal dystrophy.

Authors:  Ula V Jurkunas; Maya Bitar; Ian Rawe
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-14       Impact factor: 4.799

9.  Backbone 1H, 15N, and 13C resonance assignments of the repeated domain of human beta ig-h3 protein.

Authors:  Sangho Park; Hee-Chul Ahn; Jung-Eun Kim; In-San Kim; Bong-Jin Lee
Journal:  J Biomol NMR       Date:  2002-12       Impact factor: 2.835

10.  Denaturation and solvent effect on the conformation and fibril formation of TGFBIp.

Authors:  Heather L Grothe; Morgan R Little; Angela S Cho; Andrew J W Huang; Ching Yuan
Journal:  Mol Vis       Date:  2009-12-08       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.